Flecainide attenuates rate adaptation of ventricular repolarization in guinea-pig heart

References

• Locati EH, Maison-Blanche P, Dejode P, et al. Spontaneous sequences of onset of torsade de pointes in patients with acquired prolonged repolarization: Quantitative analysis of Holter recordings. J Am Coll Cardiol. 1995;25:1564–1575.
   PubMed Web of Science ®Google Scholar
• Panidis IP, Morganroth J. Sudden death in hospitalized patients: Cardiac rhythm disturbances detected by ambulatory electrocardiographic monitoring. J Am Coll Cardiol. 1983;2:798–805.
   PubMed Web of Science ®Google Scholar
• Denker S, Lehmann MH, Mahmud R, et al. Facilitation of macroreentry within the His-Purkinje system with abrupt changes in cycle length. Circulation. 1984;69:26–32.
   PubMed Web of Science ®Google Scholar
• Gill JS, Baszko A, Xia R, et al. Dynamics of the QT interval in patients with exercise-induced ventricular tachycardia in normal and abnormal hearts. Am Heart J. 1993;126:1357–1363.
   PubMed Web of Science ®Google Scholar
• Echt DS, Liebson PR, Mitchell B, et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. New Engl J Med. 1991; 324:781–788.
   PubMed Web of Science ®Google Scholar
• Follmer CH, Colatsky TJ. Block of delayed rectifier potassium current, IK, by flecainide and E-4031 in cat ventricular myocytes. Circulation. 1990;82:289–293.
   PubMed Web of Science ®Google Scholar
• Wang DW, Kiyosue T, Sato T, Arita M. Comparison of the effects of class I antiarrhythmic drugs, cibenzoline, mexiletine and flecainide, on the delayed rectifier K+ current of guinea-pig ventricular myocytes. J Mol Cell Cardiol. 1996;28:893–903.
   PubMed Web of Science ®Google Scholar
• Olsson SB, Edvardsson N. Clinical electrophysiologic study of antiarrhythmic properties of flecainide: Acute intraventricular delayed conduction and prolonged repolarization in regular paced and premature beats using intracardiac monophasic action potentials with programmed stimulation. Am Heart J. 1981;102:864–871.
   PubMed Web of Science ®Google Scholar
• Lim KS, Jang IJ, Kim BH, et al. Changes in the QTc interval after administration of flecainide acetate, with and without co-administered paroxetine, in relation to cytochrome P450 2D6 genotype: data from an open-label, two-period, single-sequence crossover study in healthy Korean male subjects. Clin Ther. 2010;32:659–666.
   PubMed Web of Science ®Google Scholar
• Hoffmann A, Wenk M, Follath F. Exercise-induced ventricular tachycardia as a manifestation of flecainide toxicity. Int J Cardiol. 1986;11:353–355.
   PubMed Web of Science ®Google Scholar
• Anastasiou-Nana MI, Anderson JL, Stewart JR, et al. Occurrence of exercise-induced and spontaneous wide complex tachycardia during therapy with flecainide for complex ventricular arrhythmias: A probable proarrhythmic effect. Am Heart J. 1987;113:1071–1077.
   PubMed Web of Science ®Google Scholar
• Osadchii OE, Woodiwiss AJ, Norton GR. Contractile responses to selective phosphodiesterase inhibitors following chronic beta-adrenoreceptor activation. Pflugers Arch. 2006;452:155–163.
   PubMed Web of Science ®Google Scholar
• Osadchii OE, Olesen SP. Electrophysiological determinants of hypokalemia-induced arrhythmogenicity in the guinea-pig heart. Acta Physiol (Oxf). 2009;197:273–287.
   PubMed Web of Science ®Google Scholar
• Osadchii OE. Dofetilide promotes repolarization abnormalities in perfused guinea-pig heart. Cardiovasc Drugs Ther. 2012;26:489–500.
   PubMed Web of Science ®Google Scholar
• Conard GJ, Ober RE. Metabolism of flecainide. Am J Cardiol. 1984;53:41B–51.
   PubMed Web of Science ®Google Scholar
• Pueyo E, Husti Z, Hornyik T, et al. Mechanisms of ventricular rate adaptation as a predictor of arrhythmic risk. Am J Physiol Heart Circ Physiol. 2010;298: H1577–H1587.
   PubMed Web of Science ®Google Scholar
• Viskin S, Postema PG, Bhuiyan ZA, et al. The response of the QT interval to the brief tachycardia provoked by standing: A bedside test for diagnosing long QT syndrome. J Am Coll Cardiol. 2010;55:1955–1961.
   PubMed Web of Science ®Google Scholar
• Eisner DA, Dibb KM, Trafford AW. The mechanism and significance of the slow changes of ventricular action potential duration following a change of heart rate. Exp Physiol. 2009;94:520–528.
   PubMed Web of Science ®Google Scholar
• Paul AA, Witchel HJ, Hancox JC. Inhibition of the current of heterologously expressed HERG potassium channels by flecainide and comparison with quinidine, propafenone and lignocaine. Br J Pharmacol. 2002;136:717–729.
   PubMed Web of Science ®Google Scholar
• Bentzen BH, Bahrke S, Wu K, et al. Pharmacological activation of Kv11.1 in transgenic long QT-1 rabbits. J Cardiovasc Pharmacol. 2011;57:223–230.
   PubMed Web of Science ®Google Scholar
• Coromilas J, Saltman AE, Waldecker B, et al. Electrophysiological effects of anisotropic conduction and reentry in infracted canine hearts. Circulation. 1995;91:2245–2263.
   PubMed Web of Science ®Google Scholar
• Osadchii OE, Soltysinska E, Olesen SP. Na+ channel distribution and electrophysiological heterogeneities in guinea-pig ventricular wall. Am J Physiol Heart Circ Physiol. 2011;300:H989–1002.
   PubMed Web of Science ®Google Scholar
• Osadchii OE. Flecainide-induced proarrhythmia is attributed to abnormal changes in repolarization and refractoriness in perfused guinea-pig heart. J Cardiovasc Pharmacol. 2012;60:456–466.
   PubMed Web of Science ®Google Scholar
• Grom A, Faber TS, Brunner M, et al. Delayed adaptation of ventricular repolarization after sudden changes in heart rate due to conversion of atrial fibrillation. A potential risk factor for proarrhythmia? Europace. 2005;7:113–121.
   PubMed Web of Science ®Google Scholar
• Bueno-Orovio A, Hanson BM, Gill JS, et al. Slow adaptation of ventricular repolarization as a cause of arrhythmia? Methods Inf Med. 2014;53:320–323.
   PubMed Web of Science ®Google Scholar